Skip to Main Content

Paper Details

Leveraging big data of immune checkpoint blockade response identifies novel potential targets.
Ann Oncol
18
2022
CTLA-, CTLA-4, F2RL1, GE signature, ICB, PD-1, PD-L1, PredictIO, RBFOX2, RNA-binding motif protein 9, T, T-cell, T-cell dysfunction, Tumor, anti-cytotoxic T-lymphocyte antigen 4, anti-programmed cell death protein 1, cancer, cancers, gene expression, gene signatures, malignancies, mice, pan, patients, programmed death-ligand 1, protease-activated receptor-2, tumor
Author NameAffiliation
Luc G T MorrisMemorial Sloan Kettering Cancer Center
Philippe L BedardPrincess Margaret Cancer Centre, University Health Network
Benjamin Haibe-KainsUniversity Health Network, Canada Princess Margaret Cancer Centre, University of Toronto, Canada Department ofOntario Institute for Cancer Research, Canada Department ofVector Institute for Artificial Intelligence, Dalla Lana School of Public Health
Benjamin Haibe-KainsUniversity Health Network, Canada Princess Margaret Cancer Centre, University of Toronto, Canada Department ofOntario Institute for Cancer Research, Canada Department ofVector Institute for Artificial Intelligence, Dalla Lana School of Public Health
  • 1 - 4

Datasets

Release 1.2